Therapeutic approaches to cholinergic deficiency in Lewy body diseases
- 12 October 2019
- journal article
- research article
- Published by Taylor & Francis in Expert Review of Neurotherapeutics
- Vol. 20 (1) , 41-53
Abstract
Introduction: Cortical cholinergic denervation resulting from degeneration of the nucleus basalis of Meynert (NBM) is a primary contributor to cognitive impairment and neuropsychiatric symptoms in the Lewy body diseases Parkinson disease (PD), Parkinson disease dementia (PDD), and dementia with Lewy bodies (DLB). Considering the morbidity associated with cognitive impairment and neuropsychiatric symptoms in these diseases, it is important to investigate all potential therapies to improve these symptoms. Areas covered: The authors review the current landscape of pharmacological and surgical therapies for mitigating the cortical cholinergic deficiency in PD, PDD, and DLB. Expert opinion: The cholinesterase inhibitors rivastigmine, donepezil, and galantamine are currently the primary pharmacological treatments available to improve cognition and associated neuropsychiatric symptoms in Lewy body diseases. Other possible pharmacological strategies include increasing acetylcholine release with 5-HT4 agonists or directly stimulating cholinergic receptors with muscarinic and nicotinic agonists. The side effect profile of muscarinic agonists is a deterrent to their future study, but 5-HT4 and nicotinic agonists deserve further investigation. Targeting the basal forebrain with either deep brain stimulation (DBS) or cell-based therapies is another strategy to mitigate cortical cholinergic deficiency. Before NBM DBS studies continue, it will be important to resolve issues related to targeting, stimulation pattern, and duration.Keywords
Funding Information
- Congressionally Directed Medical Research Programs (W81XWH-15-NETPR-CPA)
This publication has 168 references indexed in Scilit:
- Donepezil for dementia with Lewy bodies: A randomized, placebo‐controlled trialAnnals of Neurology, 2012
- A block to pre-prepared movement in gait freezing, relieved by pedunculopontine nucleus stimulationBrain, 2011
- MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD‐MCIMovement Disorders, 2011
- The Controlled Generation of Functional Basal Forebrain Cholinergic Neurons from Human Embryonic Stem CellsStem Cells, 2011
- Consolidation and long-term retention of an implanted behavioral memoryNeurobiology of Learning and Memory, 2011
- Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's diseaseBrain, 2009
- Sensory memory consolidation observed: Increased specificity of detail over daysNeurobiology of Learning and Memory, 2009
- Effects of engrafted neural stem cells in Alzheimer's disease ratsNeuroscience Letters, 2009
- Stereotaxic probabilistic maps of the magnocellular cell groups in human basal forebrainNeuroImage, 2008
- Experience dependent plasticity alters cortical synchronizationHearing Research, 2007